Business ❯ Finance ❯ Investments ❯ Mergers and Acquisitions

Pharmaceutical Acquisitions

GSK to Buy Nuvalent for $10.6 Billion to Bolster Lung‑Cancer Pipeline

The all‑cash purchase adds two late‑stage targeted lung‑cancer drugs under FDA review and signals CEO Luke Miels’s push to rebuild GSK’s oncology business.

19 ARTICLES

2mo ago

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

10 ARTICLES

6mo ago

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

9 ARTICLES

6mo ago

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

11 ARTICLES

7mo ago

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

12 ARTICLES

7mo ago

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

6 ARTICLES

9mo ago

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

27 ARTICLES

10mo ago

Pfizer to Buy Metsera for $4.9 Billion Upfront in Return to Obesity Drugs

10 ARTICLES

last yr.

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

24 ARTICLES

last yr.

Torrent to Acquire Controlling Stake in JB Pharma in ₹25,689 Crore Deal

27 ARTICLES

last yr.

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

9 ARTICLES

last yr.

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

4 ARTICLES

last yr.

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

3 ARTICLES

last yr.

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Pharmaceutical Acquisitions

GSK to Buy Nuvalent for $10.6 Billion to Bolster Lung‑Cancer Pipeline

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

Sun Pharma to Buy Organon for $11.75 Billion in All-Cash Deal

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

Merck to Acquire Terns for $6.7 Billion to Add Promising Leukemia Drug

USV to Acquire 79% of Wellbeing Nutrition in Rs 1,583 Crore All-Cash Deal

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

Never miss stories about

Pharmaceutical Acquisitions

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

Pfizer to Buy Metsera for $4.9 Billion Upfront in Return to Obesity Drugs

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Torrent to Acquire Controlling Stake in JB Pharma in ₹25,689 Crore Deal

BioNTech Moves to Complete $1.25 Billion Curevac Takeover

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Merck in Advanced Talks to Acquire Springworks Therapeutics for $3.5 Billion

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Never miss stories about

Pharmaceutical Acquisitions